With the use of increasingly sensitive methods for detection of the abnormal isoform of prion protein (PrP Sc ) and infectivity in prion diseases, it has recently been shown that parts of the peripheral nervous system (PNS) of bovine spongiform encephalopathy (BSE)-affected cattle may become infected. It has been reported that prions spread to the central nervous system (CNS) via the PNS in sheep scrapie, but the pathogenesis of BSE in cattle is less well understood. To determine whether parts of the PNS other than those implicated directly in the hypothetical pathogenetic spread of agent from the intestine to the CNS become involved before or after the CNS is affected, PrP Sc distribution was investigated by a highly sensitive Western blotting technique in dorsal root ganglia, stellate ganglion, phrenic, radial and sciatic nerves, adrenal gland and CNS of cattle that were inoculated orally with BSE-affected brain and culled sequentially. In experimentally BSE-affected cattle, PrP Sc was first detected in the CNS and dorsal root ganglia; subsequently, PrP Sc accumulation was detected in the peripheral nerve trunks. PrP Sc was also detected in the adrenal glands of cattle that showed clinical signs. No PrP Sc was detected in the PNS of BSE-negative cattle. This study shows that, with respect to dorsal root ganglia, a paravertebral sympathetic ganglion and the somatic nerves examined, PrP Sc is detected in the PNS during the disease course at the same time as, or after, it accumulates in the CNS.
INTRODUCTION
Bovine spongiform encephalopathy (BSE) is a fatal, neurodegenerative disorder of cattle. It belongs to a group of diseases called transmissible spongiform encephalopathies (TSEs), which also include scrapie in sheep and goats and Creutzfeldt-Jakob disease (CJD) in humans (Prusiner, 1991) . TSEs are characterized by spongiform changes in the central nervous system (CNS) (Fraser, 1979; Masters & Richardson, 1978) and by the accumulation, principally in the CNS and lymphoreticular system, of PrP Sc , a pathological, partially protease-resistant isoform of a normal cellular prion protein (PrP C ) . The conversion of PrP C to PrP Sc is thought to be central to the pathogenesis of TSEs, and PrP Sc has been recognized as a major component of the pathogen, normally referred to as a prion. PrP Sc is generally, but not exclusively, correlated with infectivity and is the only known disease-specific marker Prusiner, 1991) .
A variant form of CJD (vCJD) has been detected in the UK and several other countries, and it is thought that this disease has resulted from the consumption of BSEcontaminated beef products (Chazot et al., 1996; Will et al., 1996 Will et al., , 1998 Cousens et al., 1997) . As a consequence, BSE is considered a zoonosis. In most countries where BSE-control programmes have been introduced, the organs that have either been predicted by extrapolation from sheep scrapie data or demonstrated to be infectious in cattle are classified as specified risk materials (SRM). These tissues are excluded from the human diet and destroyed, irrespective of the outcome of post-mortem testing for BSE.
Whilst much has been learned about the pathogenesis of BSE in cattle by examination of tissues from experimentally infected cattle, killed at intervals throughout the disease course, infectivity has been detected consistently only in the distal ileum, the CNS and certain peripheral nervous system (PNS) ganglia: dorsal root ganglia (DRG) and trigeminal ganglion (Wells et al., 1998 (Wells et al., , 1999 (Wells et al., , 2005 . Rarely, in experimentally infected cattle, infectivity has also been detected in bone marrow and tonsil (Wells et al., 1999 (Wells et al., , 2005 . Until recently, in naturally infected clinical cases of BSE, infectivity had been detected only in the brain, spinal cord and retina by bioassay in wild-type mice (Fraser & Foster, 1994; MAFF, 1995) . This apparently restricted tissue distribution of the BSE agent in cattle, compared with at least some other TSEs, may partially be a reflection of limitations of the assay sensitivity. Although assays have been conducted by intracerebral inoculation of cattle (Wells et al., 2005) , evidence of infectivity in tissues to which humans may be exposed, such as muscle, peripheral nerves and lymph nodes, has remained elusive.
Recently, through the use of transgenic mice overexpressing bovine PrP C (Tgbov XV mice), infectivity was detected in the brain, spinal cord, retina, optic, facial and sciatic nerves and distal ileum of a naturally infected cow at the terminal stage of BSE (Buschmann & Groschup, 2005) . In addition, detection of PrP Sc has been reported in the PNS and adrenal glands of a natural case of BSE in Japan . PrP Sc was also detected in the peripheral nerves of two BSE-positive cows that were detected during surveillance of slaughtered cattle (Iwata et al., 2006) . Although Iwata et al. (2006) reported that the BSE-positive cattle were not clinically affected, the clinical signs reported at ante-mortem examination were inclusive of those recorded in British BSE-affected cattle. It is therefore probable that these animals were at least in the early stages of clinical disease.
These data indicate that PrP
Sc and/or infectivity can be detected outside the CNS and distal ileum, at least in the later stages of disease, and that the presence of agent in the PNS may represent a risk to consumers, as PNS structures are not specifically designated SRM, and are thus not removed from the food chain. In order to facilitate more accurate estimations of risk, in the context of control programmes including the testing of cattle entering the food chain, it was felt to be necessary to investigate whether PrP Sc could be detected in parts of the PNS other than those implicated directly in the hypothetical pathogenetic spread of agent from the intestine to the CNS van Keulen et al., 2000; McBride et al., 2001; Wells & Wilesmith, 2004) . In particular, it was of interest to determine whether PrP Sc was present before, or only after, detection in the CNS, or after the onset of clinical signs. In this study, we investigated PrP Sc accumulation in the PNS and adrenal gland of naturally infected BSE cases from the UK in order to confirm previous results from cattle in Japan. In addition, using samples from cattle in an experimental time-course study, we investigated the temporal relationship between detection of PrP Sc in the CNS and certain PNS structures following oral exposure to BSE-infected brain material.
In addition, infectivity assays on selected tissues were conducted in transgenic mice expressing the bovine prion protein (PrP) gene (TgBoPrP).
METHODS
Tissue samples from cattle. All samples examined in this study were provided by the TSE Archive of the VLA, Addlestone, UK. For confirmation of earlier Japanese results, we examined the PNS: cervical and thoracic DRG (pooled C3-5 and T7-9), trigeminal, cranial cervical and thoracic ganglia, sciatic, vagus and splanchnic nerves and the adrenal gland from five clinically suspect, BSEconfirmed cases and five clinically suspect animals that were negative after diagnostic examinations of brain. These served as controls, as they presented with neurological signs consistent with BSE.
In the second part of the experiment, we examined the following tissues: brainstem, spinal cord (segments C1-2, or C2-3 and T9-10), DRG (pooled from segments C3-5 and T7-9), stellate ganglion, phrenic and radial nerves and adrenal gland harvested from cattle that were challenged orally at the VLA with either 100 or 1 g BSE-infected brainstem homogenate from clinically affected donors, and culled sequentially. The infectivity titre of the inoculum was determined previously by end-point titration in RIII mice to be 10 3.1 mouse intracerebral and intraperitoneal units ID 50 g 21 , (M. E. Arnold and others, unpublished data), which is similar to other contemporary titrations in these mice of infectivity of brainstem from clinical cases of BSE (data not shown). Samples collected between 27 and 42 months post-exposure from the 100 g dose group, and between 36 and 51 months post-challenge in the 1 g dose group (Table 1) , were selected for testing on the basis of prior knowledge of the time points in the sequential kill studies when PrP Sc was first detected in the CNS (Wells et al., 1998; M. E. Arnold and others, unpublished data) . The selection of material was judged to ensure that some samples were available from time points before PrP Sc was detected by immunohistochemistry (IHC) in the CNS. Sample sets were not complete for all animals from the original experiments, as supply was dependent on stocks remaining after use in other studies. In total, 376 tissues obtained from 31 cattle challenged experimentally with a 100 g dose of BSE brainstem homogenate, and 14 challenged with a 1 g dose, were examined. A further seven undosed, control cattle, age-matched approximately to challenged animals killed at 27, 30, 33, 36, 42, 44 and 52 months after dosing, provided corresponding control samples.
Processing of tissue samples. PrP Sc was extracted from peripheral tissues by a method described previously (Shimada et al., 2005) . Briefly, the PNS tissues and adrenal glands were suspended in 0.8 ml of a detergent buffer containing 50 mM Tris/HCl (pH 7.5), 2 % (v/v) Triton X-100, 0.5 % (v/v) N-lauroylsarcosine (Sarkosyl; Nacalai), 100 mM NaCl, 5 mM MgCl 2 , 2 mM CaCl 2 , 20 mg collagenase and 40 mg DNase I, and incubated at 37 uC for 2 h with constant rotation with a metal bead (Metal corn; Yasui Kikai). The homogenate was digested with proteinase K (PK; Roche Diagnostics) (final concentration, 60 mg ml 21 ) at 37 uC for 1 h. PK digestion was terminated with 2 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride 
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(Pefabloc; Roche Diagnostics). The homogenate was centrifuged at 68 000 g for 20 min (Optima MAX-E/TLA-100.3; Beckman) at room temperature (RT). The supernatant was discarded and the pellet was suspended in 6.25 % (w/v) Sarkosyl (Sigma) in 10 mM Tris/HCl (pH 7.5) and incubated at RT for 1 h with constant rotation; subsequently, it was centrifuged at 9000 g for 5 min (6200/AF-2730; Kubota). Sodium phosphotungstate was added to the supernatant to a final concentration of 0.3 % (v/v) and incubated at 37 uC for 30 min with constant rotation. Pellets were obtained by centrifugation at 20 000 g for 30 min (6200/AF-2730; Kubota). PrP Sc was enriched from the brain according to a method described previously . The CNS tissues were homogenized in a buffer containing 100 mM NaCl and 50 mM Tris/HCl (pH 7.6). The homogenate was mixed with an equal volume of detergent buffer containing 4 % (w/v) Zwittergent 3-14 (Calbiochem), 1 % (w/v) Sarkosyl, 100 mM NaCl and 50 mM Tris/HCl (pH 7.6) and then incubated with 0.25 mg collagenase, followed by incubation with PK (final concentration, 40 mg ml 21 ) at 37 uC for 30 min. PK digestion was terminated with 2 mM Pefabloc. The sample was mixed with 2-butanol:methanol (5:1) and then centrifuged at 20 000 g for 10 min (6200/AF-2730; Kubota).
Western blotting (WB) analysis. The pellets were resuspended in a gel-loading buffer containing 2 % SDS and heated at 100 uC for 6 min. The samples were separated by SDS-PAGE (12 % gel) and blotted electrically onto a PVDF membrane. The blotted membrane was incubated with anti-PrP monoclonal antibody (mAb) T2 conjugated to horseradish peroxidase at RT for 1 h. Signals were developed with a chemiluminescent substrate (SuperSignal; Pierce Biotechnology) (Hayashi et al., 2004) .
Infectivity assays. The transmissibility of infection from brain, vagus nerve and adrenal gland of natural cases of BSE, tissues that were found to contain PrP Sc , was bioassayed in transgenic (Tg) mice expressing bovine PrP [Tg(BoPrP)4092HOZ/Prnp 0/0 ; Tg(BoPrP)]. These mice, kindly supplied by Dr S. B. Prusiner, are susceptible to BSE prions and exhibit an incubation period of ,250 days (Scott et al., 1997) . The tissues were each homogenized in 9 vols PBS by a multi-bead shocker (Yasui Kikai) and centrifuged at 1000 g for 5 min (6200/AF-2730; Kubota) at RT; the supernatant was used as the inoculum. Female Tg(BoPrP) mice (3 weeks old) were inoculated intracerebrally with 20 ml supernatant. After inoculation, the clinical status of the mice was monitored daily to assess the onset of neurological signs. Diseased mice were sacrificed and subjected to PrP Sc examination as described previously (Yokoyama et al., 2001) .
RESULTS

PrP
Sc detection in the PNS and adrenal gland of naturally BSE-affected cattle
Representative results of WB analysis of the vagus nerve and adrenal gland of naturally infected cattle are shown in Fig. 1(a, b) . Samples from the diagnostically unconfirmed cattle were negative. The signal intensity from BSE-positive cattle differed between samples and from animal to animal, but typical triple banding was observed in positive tissues, including the adrenal gland and vagus nerve. A weak signal was detected from the sciatic nerve (Fig. 1c) . The results of the WB analysis are summarized in Table 2 . In addition to the trigeminal ganglion and the mid-cervical and midthoracic DRG, PrP Sc was also detected in the peripheral nerves, adrenal gland and thoracic ganglia.
Sc detection in the CNS of cattle challenged orally with BSE-infected brainstem
The WB results for individual animals are given in Tables 3  and 4 according to time after inoculation. The results of WB analysis of brainstem and spinal cord were compared with the BSE status of the cattle, as determined previously by IHC examination of the brainstem. The WB results for CNS tissues were completely in accord with the previous diagnoses based on IHC. (Table 5) . (b) Lanes 1-10, vagus nerve (100 mg tissue eq.). Sample from animal 19591 (lane 4) was subjected to transmission study (Table 5) . (c) Lanes 1-10, sciatic nerve (100 mg tissue eq.). (d) Lanes 1-9, midbrain (5 mg tissue eq.). BSE status (shown underneath each gel) was determined by IHC examination of the medulla-obex at VLA, Weybridge, UK: +, BSE-positive cattle; ", BSE-negative cattle. Lanes a-c, mouse scrapie-infected brain was used as the positive control (a, 0.4 mg brain eq.; b, 1.6 mg brain eq.; c, 6.4 mg brain eq.). Molecular markers are shown on the left (in kDa).
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PrP
Sc detection in the PNS and adrenal glands of cattle challenged orally with BSE-infected brainstem
Sc was detected in PNS by WB analysis, but only inconsistently in those animals diagnosed as BSE-positive on previous CNS IHC examinations (M. E. Arnold and others, unpublished data) (Tables 3 and 4) . Furthermore, irrespective of dose, DRG were positive only in animals in which the corresponding level of spinal cord was positive, and PrP Sc was not always detected at both cervical and thoracic levels of DRG. PrP Sc was detected in the stellate ganglion in three of six animals of the 100 g dose group that were killed 36 months after inoculation, concurrent with DRG involvement. PrP Sc was detected in the phrenic nerve in the single animal of the 100 g dose group that was analysed 35 months after inoculation, and in one of six animals of the 100 g dose group that were killed 36 months after inoculation, in which CNS and certain ganglia were also positive. PrP Sc was not detected in the radial nerve, but was found in samples of the sciatic nerve (one in the 100 g dose group and two in the 1 g dose group), all in animals with positive CNS and ganglia. Whilst PrP Sc was detected in DRG and stellate ganglion of occasional preclinical animals, PrP Sc was detected in peripheral nerves only in those animals with definite clinical signs at the time of euthanasia. PrP Sc was detected in adrenal gland from three samples from the 100 g dose-group cattle, which were also clinically affected. Detection of PrP Sc was erratic in relation to time post-inoculation (Tables 3 and 4 ). All tests were negative in challenged and control cattle designated previously as BSE-negative by IHC (Fig. 1d) .
Sc -positive vagus nerve and adrenal gland harbour infectivity
The attack-rate and incubation-period data of the mice inoculated with PrP Sc -positive vagus nerve and adrenal gland are shown in Table 5 . Typical PrP Sc banding was detected in diseased Tg(BoPrP) mouse brains (Fig. 2) . The glycoform pattern and molecular mass of PrP Sc in Tg(BoPrP) mice were identical to those of the BSE-affected cattle brain.
DISCUSSION
This was an opportunistic study, intended to build upon data arising from the Japanese surveillance programme, but also to expand an understanding of the pathogenesis of BSE in cattle in the late incubation period, around the time of initial CNS involvement. The data obtained in this study indicate that PrP Sc accumulates in the PNS and adrenal glands of BSE-affected cattle and that this accumulation appears to coincide with, or follow rather than precede, accumulation in the CNS. Observations reported previously for the PNS and adrenal gland of a BSE case, and for the PNS of two cows slaughtered for human consumption in Japan Iwata et al., 2006) , have now been repeated in five clinical cases from the UK by using the methods described here. This highly sensitive WB method has also detected PrP Sc accumulation in the PNS and/or adrenal gland of five further natural BSE cases detected during the surveillance of fallen stock in Japan (data not shown). These data reinforce the results of Buschmann & Groschup (2005) , which confirmed the presence of infectivity in the PNS of a clinical case of BSE in Germany. Based on these results, it seems likely that PrP Sc accumulation in the PNS during the clinical stages of infection may be the rule in BSE, rather than the exception. PrP Sc accumulation in the PNS has been reported in naturally and experimentally scrapie-affected sheep and hamsters, and in CJD-affected humans (Groschup et al., 1996 (Groschup et al., , 1999 Beekes et al., 1998; Haik et al., 2003; Favereaux et al., 2004; Head et al., 2004; Ishida et al., 2005) . As shown in Fig. 1 , the PrP Sc signal intensity varied between samples and among cattle. Based on a comparison of the signal intensity in the WB analysis, the amount of PrP Sc present in the PNS or adrenal glands was estimated to be ,1/120 of that present in the brain.
By testing cattle from an experimental sequential kill study completed at the VLA, it was proposed to obtain further data on the correlation of CNS and PNS PrP Sc detection relative to time after exposure and thereby extend previous studies (Wells et al., 1998 (Wells et al., , 2005 . Limitations on the availability of certain samples, particularly vagus and splanchnic nerves and abdominal autonomic nervous system ganglia, prevented examinations that would have provided 
ND, Not done. *Clinical status: +/2, probable signs; +, definite signs [for definition and application of clinical categories, see Wells & Hawkins (2004) ]. DBSE status (+, positive; 2, negative) as determined by IHC examination of midbrain, rostral medulla and medulla-obex (M. E. Arnold and others, unpublished data).
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Journal of General Virology 88 opportunities to investigate potential routes of entry of agent to the CNS. Previous studies have demonstrated that PrP Sc deposition in the CNS of BSE-affected cattle is targeted to certain neuroanatomical areas and is not uniform. In this study, PrP Sc detection in the brainstem and two levels of spinal cord tested by WB analysis confirmed previous results of the BSE status of experimentally infected cattle, based upon IHC examination of three levels of brainstem (M. E. Arnold and others, unpublished data).
Interestingly, PrP
Sc was detected simultaneously in different parts of the CNS (Tables 3 and 4) , even in animals that were only in the earlier stages of clinical disease, suggesting perhaps that, once entry has occurred, spread of agent throughout the CNS is a process involving periods that are shorter than the sequential time intervals in the experimental kill study. In this study, PrP Sc detection in the PNS was an infrequent finding in the late preclinical and the clinical stages of BSE, and the available evidence would be consistent with spread from the CNS to the PNS structures examined (DRG, stellate ganglion, phrenic, radial and sciatic nerves) and adrenal glands. The results did not present inconsistencies that would refute the current understanding of peripheral pathogenesis in models of TSE after oral exposure ; van Keulen et al., Table 4 . WB detection of PrP 
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2000; McBride et al., 2001) . The apparently restricted involvement of lymphoid tissues (Buschmann & Groschup, 2005; Wells et al., 2005) and enteric plexuses (Terry et al., 2003) in BSE pathogenesis in cattle suggests possible differences from events in experimental models of TSE pathogenesis. Such differences can only be investigated by experiments conducted in the natural host species. It is likely from epidemiological data and experimental studies (Wells et al., 2007) that the 1 g dose group in these experimental exposures of cattle approximates the majority of field-case exposures, perhaps suggesting less relevance to risk management of positive results from tissues taken from an animal that has been dosed with 100 g. However, the data here do not suggest marked differences between the dose groups and are insufficient for 1 g-dosed animals to indicate a reduced involvement of PNS tissues relative to dose or timing of positive results in other tissues. Although sparse PrP
Sc accumulation was observed in the PNS of experimentally infected cattle, PrP
Sc was detected in all PNS tissues examined from natural BSE cases (Tables 2, 3 and 4). This may indicate a progressive involvement of PNS in the clinical phase of disease and has implications for the risk assessment of tissues from such animals should they escape detection at slaughter.
In natural cases of clinically BSE-affected cattle, infectivity, detected by bioassay in wild-type mice, has been found only in the CNS (Fraser & Foster, 1994) . In orally inoculated cattle, infectivity has been detected in the brain, spinal cord, distal ileum, DRG and trigeminal ganglion in the late incubation period by wild-type mouse assays (Wells et al., 1994 (Wells et al., , 1996 (Wells et al., , 1998 . Infectivity was also detected by wildtype mouse assay in bone marrow, but only at a single time point in clinically affected, experimentally infected cattle (Wells et al., 1999) . Intracerebral inoculation of calves with tissues collected from experimentally infected cattle indicated further that palatine tonsil, not detected previously as being infective by wild-type mouse assay, was infective at 10 months post-oral infection (Wells et al., 2005) . Inoculation of calves has also led to the detection of infectivity in the lymphoid tissues of nictitating membranes (G. A. H. Wells, unpublished data; http://www.seac.gov.uk/papers/ seac85-3.pdf) from a pool of nictitating membranes collected from naturally infected cows.
Recently, studies using genetically modified mice (Tgbov XV), shown to be 10 000-fold more sensitive than assay in RIII mice and 10-fold more sensitive than assays by the intracerebral route in cattle, have enabled the detection of amounts of infectivity lower than the previous threshold of detection (Buschmann & Groschup, 2005) . The studies also expanded the range of tissues assayed and demonstrated BSE infectivity in brain, spinal cord, retina, optic nerve, distal ileum, peripheral nerves (facial and sciatic nerves) and the semitendinosus muscle. With respect to the latter tissue, it remains unclear whether the small amounts of infectivity present were attributable to muscle tissue per se or to the peripheral nerve or lymphoid tissue content of the muscle.
In the assay study described here, we have confirmed that the detection of PrP Sc is indicative of the presence of infectivity in vagus nerve and adrenal gland of BSE-affected cattle in the clinical stage of disease. This supports the use of PrP Sc detection as a surrogate for detection of infectivity in expanding our understanding of the pathogenesis of BSE. However, tissues without detectable PrP Sc accumulation may harbour prion infectivity as, despite the highly sensitive PrP Sc -detection procedure used in this study, there are clear precedents for the occurrence of infectivity in the absence of detectable PrP Sc . The incubation periods of vagus nerve and adrenal gland suggest that the estimated infectivity in these tissues was 2-2.5 logs lower than that of the CNS (Safar et al., 2002) . PrP Sc accumulation in the adrenal gland, vagus nerve and stellate ganglion may result from extension from a primary routeing of BSE prions via sympathetic and parasympathetic pathways to the CNS, or secondary spread from the CNS. The adrenal gland, for example, has a rich sympathetic supply associated with the capsule and the medulla that could be notionally infected primarily or secondarily via the splanchnic nerves. The vagus nerve provides the parasympathetic inervation to the intestine and enters the CNS at the medulla, and the stellate ganglion is part of the paravertebral sympathetic chain of ganglia. Interestingly, there are no precedents for a primary role for sensory neural pathways in the pathogenesis of BSE and, hence, DRG infectivity is considered to have spread from the CNS.
Quite clearly, our data indicate that a consumer-protection policy that is based solely on SRM removal, as currently designated, will not eliminate potential exposure to BSE infectivity completely in the carcass of an animal that is CNS-positive, i.e. clinically affected animals or those close to the onset of clinical disease. For such animals, a positive BSE test at the level of the obex followed by destruction of the carcasses would provide greater consumer protection than the removal of SRM alone. It remains to be determined whether the additional protection is actually significant, taking into account the quantity of infectivity present in amounts of PNS likely to be consumed. Nevertheless, the data provided here can contribute to review of risk assessments in relation to bovine PNS tissues.
